About
Biofluid-based molecular diagnostic tests
Areas of Focus
Categories
Diagnostics
Clinical Trials (10)
View allTotal Trials
10
As Lead Sponsor
9
As Collaborator
1
Total Enrollment
10,682
By Phase
NA: 1
By Status
UNKNOWN: 3COMPLETED: 3NOT_YET_RECRUITING: 1TERMINATED: 1SUSPENDED: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline10 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05572099Lead Sponsor
ExoDx Prostate Evaluation in Active Surveillance Patient Population
N/AUnknown
750 participants
Started: Oct 1, 2022 · Completed: Oct 31, 2023
NCT05072951Lead Sponsor
Urine Biomarker for Kidney Transplant Rejection
N/ANot yet recruiting
750 participants
Started: Oct 31, 2021 · Completed: Oct 31, 2025
NCT04720599Lead Sponsor
Clinical Evaluation of ExoDx Prostate(IntelliScore) in Men Presenting for Initial Prostate Biopsy
N/ACompleted
120 participants
Started: Jun 1, 2020 · Completed: Jun 1, 2021
NCT04357717Lead Sponsor
ExoDx Prostate Evaluation in Prior Negative Prostate Biopsy Setting
N/ATerminated
150 participants
Started: Mar 15, 2020 · Completed: Sep 1, 2021
NCT03235687Lead Sponsor
Decision Impact Trial of the ExoDx Prostate (IntelliScore)
NAUnknown
1,000 participants
Started: Jul 19, 2017 · Completed: Sep 29, 2023
Locations (1)
Headquarters
Martinsried, Germany
Map
Loading map...